Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178921 | SCV000231101 | benign | not specified | 2015-05-18 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000178921 | SCV000269748 | benign | not specified | 2014-11-24 | criteria provided, single submitter | clinical testing | Asp142Asp in exon 5 of RIT1: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 2.6% (115/4406) of Af rican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs34831194). |
Prevention |
RCV000178921 | SCV000307148 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000588435 | SCV000518593 | benign | not provided | 2016-04-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001082335 | SCV000554657 | benign | Noonan syndrome 8 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588435 | SCV000698733 | benign | not provided | 2017-07-04 | criteria provided, single submitter | clinical testing | Variant summary: The RIT1 c.375C>T (p.Asp125Asp) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE site of SF2/ASF. However, these predictions have yet to be confirmed by functional studies. This variant was found in 291/121318 control chromosomes (5 homozygotes), predominantly observed in the African subpopulation at a frequency of 0.02665 (277/10394). This frequency is about 2132 times the estimated maximal expected allele frequency of a pathogenic RIT1 variant (0.0000125), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, multiple clinical diagnostic laboratories/reputable databases have classified this variant as benign. Taken together, this variant is classified as benign. |
Genome Diagnostics Laboratory, |
RCV001813423 | SCV002060615 | benign | Noonan syndrome and Noonan-related syndrome | 2021-06-07 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000178921 | SCV002066083 | benign | not specified | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345624 | SCV002623023 | benign | Cardiovascular phenotype | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001082335 | SCV004050451 | benign | Noonan syndrome 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001082335 | SCV004564932 | benign | Noonan syndrome 8 | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000588435 | SCV005282247 | benign | not provided | criteria provided, single submitter | not provided |